Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Detalles Bibliográficos
Autores principales: Bardy-Bouxin, Nathalie, Matczak, Ewa, Devgan, Geeta, Woloj, Mabel, Shapiro, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340369/
https://www.ncbi.nlm.nih.gov/pubmed/25733805
http://dx.doi.org/10.2147/BTT.S79507
_version_ 1782359018043342848
author Bardy-Bouxin, Nathalie
Matczak, Ewa
Devgan, Geeta
Woloj, Mabel
Shapiro, Mark
author_facet Bardy-Bouxin, Nathalie
Matczak, Ewa
Devgan, Geeta
Woloj, Mabel
Shapiro, Mark
author_sort Bardy-Bouxin, Nathalie
collection PubMed
description
format Online
Article
Text
id pubmed-4340369
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43403692015-03-02 Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib Bardy-Bouxin, Nathalie Matczak, Ewa Devgan, Geeta Woloj, Mabel Shapiro, Mark Biologics Letter Dove Medical Press 2015-02-19 /pmc/articles/PMC4340369/ /pubmed/25733805 http://dx.doi.org/10.2147/BTT.S79507 Text en © 2015 Bardy-Bouxin et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Letter
Bardy-Bouxin, Nathalie
Matczak, Ewa
Devgan, Geeta
Woloj, Mabel
Shapiro, Mark
Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
title Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
title_full Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
title_fullStr Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
title_full_unstemmed Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
title_short Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
title_sort response to miller et al: resistant mutations in cml and ph(+) all – role of ponatinib
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340369/
https://www.ncbi.nlm.nih.gov/pubmed/25733805
http://dx.doi.org/10.2147/BTT.S79507
work_keys_str_mv AT bardybouxinnathalie responsetomilleretalresistantmutationsincmlandphallroleofponatinib
AT matczakewa responsetomilleretalresistantmutationsincmlandphallroleofponatinib
AT devgangeeta responsetomilleretalresistantmutationsincmlandphallroleofponatinib
AT wolojmabel responsetomilleretalresistantmutationsincmlandphallroleofponatinib
AT shapiromark responsetomilleretalresistantmutationsincmlandphallroleofponatinib

Ejemplares similares